From October 1, 2022 to November 21, 2022, the company has repurchased 1,211,505 shares, representing 0.22% for CNY 55.98 million. With this, the company has completed the repurchase of 2,022,344 shares, representing 0.37% for CNY 100 million under the buyback announced on August 4, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.75 CNY | -0.14% | -3.59% | -41.35% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.35% | 1.11B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.